Cargando…
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
Autores principales: | Övergaard, Ninja, Lia, Kjersti, Asdahl, Peter, Wikman, Per, Glimelius, Ingrid, Lagerlöf., Ingemar, Johansson, Ann-Sofie, Hansson, Lotta, Enblad, Gunilla, Linderoth, Johan, Goldkuhl, Christina, Fosså, Alexander, Kamper, Peter, Molin, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642063/ http://dx.doi.org/10.1097/01.HS9.0000890896.83681.49 |
Ejemplares similares
-
T084: Treatment patterns and outcomes for Hodgkin’s Lymphoma (HL) patients (pts) aged 60 and older: a report from the Brazilian Prospective Hodgkin’s lymphoma Registry
por: Goveia, Lilian, et al.
Publicado: (2022) -
T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma
por: Upshaw, Jenica, et al.
Publicado: (2022) -
P085: Epidemiology and results of the first line therapy of HIV-related Hodgkin Lymphoma: Russian retrospective multicenter study
por: Chekalov, Andrey, et al.
Publicado: (2022) -
Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years
por: Wahlin, Björn Engelbrekt, et al.
Publicado: (2021) -
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
por: Lagerlöf, Ingemar, et al.
Publicado: (2022)